Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

On Location

Updates from major medical meetings in the field of hematology/oncology
Five-Year Results of SEQUOIA Trial Show Maintenance of Benefit for Patients With Del(17p) Treatment-Naïve CLL Treated With Zanubrutinib Free
Anna Azvolinsky, PhD
July 17, 2025
Patients With CMML Show Durable Response to Lenzilumab, Azacitidine Combo Free
Leah Lawrence
July 17, 2025
R-Pola-Glo Shows High Response Rates in Unfit, Older Patients With DLBCL Free
Leah Lawrence
July 17, 2025
Iptacopan Increases Hemoglobin in Paroxysmal Nocturnal Hemoglobinuria Free
Lara C. Pullen, PhD
July 16, 2025
Azacitidine Demonstrates Sustained Efficacy in VEXAS Syndrome Free
Khylia Marshall
July 16, 2025
Another Potential Product for Fibrinogen Concentrate for Congenital Fibrinogen Deficiency Free
Ruth Jessen Hickman, MD
July 16, 2025
Small Activating RNA-Mediated Induction of HBG Gene Via In Vivo Delivery Shows Potential in SCD Free
Katie Robinson
July 16, 2025
Trispecific Antibody Safe With High Efficacy in Phase I R/R MM Study Free
Katie Robinson
July 16, 2025
Ropeg May Provide New Treatment Option for Essential Thrombocythemia Free
Ruth Jessen Hickman, MD
July 16, 2025
Subcutaneous Mosunetuzumab Could Be Administered in Community Setting to Patients With Follicular Lymphoma Free
Lara C. Pullen, PhD
July 16, 2025
Ibrutinib-Venetoclax Combination Shows High Rate of Response in Patients With Treatment-Naïve MCL Free
Thomas R. Collins
July 16, 2025
Results of Phase III Trial of Rusfertide Could Change Polycythemia Vera Treatment Free
Ruth Jessen Hickman, MD
July 16, 2025
Phase II Results Point Toward a New Era in Treating Acute Myeloid Leukemia Free
Lara C. Pullen, PhD
July 16, 2025
Pneumococcal Meningitis Mortality Remains High in Children in France With SCD Free
Katie Robinson
June 24, 2025
Isatuximab-Based Quad Therapy Delivers Improved MRD Negativity in NDMM Free
Thomas R. Collins
June 24, 2025
Low Rates of High-Grade Toxicities Seen With Fresh CAR T-Cell Therapy in R/R NHL Free
Katie Robinson
June 24, 2025
Ultrasensitive ctDNA at First-Line Therapy for DLBCL Predicts Remission Free
Lara C. Pullen, PhD
June 16, 2025
Large Database Study Maps Treatment Use Among Elderly, Veteran Patients With DLBCL Free
Anna Azvolinsky, PhD
June 10, 2025
MRD-Guided Approaches Yield Good Results With IsaKRD in MM Free
Thomas R. Collins
June 10, 2025
Cell-of-Origin, CNS-IPI Scores Help Predict Secondary CNS Lymphoma Risk in DLBCL Free
Thomas R. Collins
June 10, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
July 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals